Toripalimab & PDTPDT For Induction Therapy For Head And Neck Cancer

Sponsor:

Massachusetts General Hospital

Code:

NCT07214987

Conditions

Squamous Cell Carcinoma

Head and Neck Cancer Squamous Cell Carcinoma

Head and Neck Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Toripalimab-tpzi

Cisplatin

Docetaxel

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-25. This information was provided to ClinicalTrials.gov by Massachusetts General Hospital on 2026-07-14.